Adoptive cell therapy in metastatic melanoma

Adoptive cell therapy in metastatic melanoma

Publication date: Sep 28, 2019

Maartje Rohaan, MD, Netherlands Cancer Institute, Amsterdam, The Netherlands, outlines her optimism about the use of adoptive cell therapy in metastatic melanoma, based off of both her own research and on what she heard at ESMO 2019. This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

Concepts Keywords
Amsterdam Cancer
Antigens Melanoma
Barcelona Tumor
Clinical Trial RTT
Egg Medicine
Melanoma Health
Netherlands Clinical medicine
Spain Medical physics
Toxicity
Tumor

Semantics

Type Source Name
disease MESH melanoma
disease DOID melanoma
pathway BSID Melanoma
disease MESH Cancer
disease DOID Cancer

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *